CPIX Cumberland Pharmaceuticals Inc. Stock Quote

CPIX [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-0.43	Insider Own	39.10%	Shs Outstand	15.03M	Perf Week	2.32%
Market Cap	40.15M	Forward P/E	53.00	EPS next Y	0.05	Insider Trans	0.00%	Shs Float	8.54M	Perf Month	-16.40%
Income	-6.50M	PEG	-	EPS next Q	-0.07	Inst Own	26.20%	Short Float	1.25%	Perf Quarter	-19.94%
Sales	37.40M	P/S	1.07	EPS this Y	27.80%	Inst Trans	-0.10%	Short Ratio	1.94	Perf Half Y	-8.93%
Book/sh	3.13	P/B	0.85	EPS next Y	-	ROA	-3.40%	Target Price	-	Perf Year	-32.05%
Cash/sh	-	P/C	-	EPS next 5Y	30.00%	ROE	-6.90%	52W Range	2.58 - 4.06	Perf YTD	-10.17%
Dividend	-	P/FCF	7.58	EPS past 5Y	-64.60%	ROI	-10.40%	52W High	-34.65%	Beta	0.23
Dividend %	-	Quick Ratio	1.50	Sales past 5Y	2.20%	Gross Margin	77.40%	52W Low	2.71%	ATR	0.09
Employees	90	Current Ratio	1.90	Sales Q/Q	10.80%	Oper. Margin	-16.90%	RSI (14)	34.11	Volatility	2.07% 2.96%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	47.00%	Profit Margin	-8.90%	Rel Volume	0.42	Prev Close	2.66
Shortable	Yes	LT Debt/Eq	0.32	Earnings	May 11 AMC	Payout	-	Avg Volume	55.00K	Price	2.65
Recom	-	SMA20	-7.65%	SMA50	-13.83%	SMA200	-15.85%	Volume	24,656	Change	-0.38%

Nov-12-12

Reiterated

UBS

Neutral

$6.50 → $5

Feb-01-11

Reiterated

UBS

Neutral

$8 → $6.50

Dec-16-10

Downgrade

UBS

Buy → Neutral

$10 → $8

Aug-17-10

Reiterated

UBS

Buy

$11 → $10

Aug-17-10

Reiterated

Morgan Joseph

Buy

$15 → $10

Aug-17-10

Downgrade

Jefferies

Buy → Hold

$13 → $5.50

May-14-10

Reiterated

Morgan Joseph

Buy

$21 → $15

May-04-21 04:05PM	Cumberland Pharmaceuticals To Announce First Quarter 2021 Financial Results PR Newswire
Mar-09-21 06:45PM	Cumberland Pharmaceuticals (CPIX) Beats Q4 Earnings and Revenue Estimates Zacks
04:26PM	Recap: Cumberland Q4 Earnings Benzinga
04:05PM	Cumberland Pharmaceuticals Reports 9% Revenue Growth In 2020 PR Newswire
01:30PM	Cumberland Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-08-21 10:08AM	Cumberland Earnings Preview Benzinga
Mar-02-21 04:05PM	Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2020 Financial Results PR Newswire
Feb-17-21 12:59AM	Is Cumberland Pharmaceuticals (NASDAQ:CPIX) A Risky Investment? Simply Wall St.
Nov-27-20 05:22PM	Where Do Hedge Funds Stand On Cumberland Pharmaceuticals, Inc. (CPIX)? Insider Monkey
Nov-17-20 11:05AM	Introducing RediTrex®, A New Methotrexate Delivery System PR Newswire
Nov-10-20 05:45PM	Cumberland Pharmaceuticals (CPIX) Q3 Earnings and Revenues Surpass Estimates Zacks
05:21PM	Recap: Cumberland Q3 Earnings Benzinga
04:05PM	Cumberland Pharmaceuticals Reports Third Quarter 2020 Financial Results & Company Update PR Newswire
02:30PM	Cumberland Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Nov-09-20 10:28AM	Cumberland's Earnings: A Preview Benzinga
Nov-03-20 04:05PM	Cumberland Pharmaceuticals To Announce Third Quarter 2020 Financial Results PR Newswire
12:30PM	Earnings Preview: Cumberland Pharmaceuticals (CPIX) Q3 Earnings Expected to Decline Zacks
Sep-03-20 08:47AM	Would Shareholders Who Purchased Cumberland Pharmaceuticals' (NASDAQ:CPIX) Stock Three Years Be Happy With The Share price Today? Simply Wall St.
Aug-18-20 09:35AM	Newly Published Literature Supports Use Of Caldolor® For Postoperative Pain And Reduction Of Opioid Use PR Newswire
Aug-11-20 05:35PM	Cumberland Pharmaceuticals (CPIX) Q2 Earnings and Revenues Beat Estimates Zacks
05:20PM	Cumberland: Q2 Earnings Insights Benzinga
04:05PM	Cumberland Pharmaceuticals Reports Second Quarter 2020 Financial Results & Company Update PR Newswire
Aug-10-20 11:04AM	Earnings Preview: Cumberland Benzinga
Aug-04-20 04:05PM	Cumberland Pharmaceuticals To Announce Second Quarter 2020 Financial Results PR Newswire
Jul-20-20 08:35AM	Caldolor® Demonstrates Significant Reduction Of Opioid Use In Orthopedic Trauma Patients PR Newswire
Jun-15-20 12:00PM	All You Need to Know About Cumberland (CPIX) Rating Upgrade to Buy Zacks +5.36%
Jun-03-20 11:09AM	Edited Transcript of CPIX earnings conference call or presentation 18-Mar-20 8:30pm GMT Thomson Reuters StreetEvents
May-27-20 06:00PM	Is Cumberland Pharmaceuticals (CPIX) A Good Stock To Buy Now? Insider Monkey -7.63%
May-26-20 04:05PM	New Publication Reveals Real-World Usage of Vibativ® In Patients With Bacteremia Or Endocarditis PR Newswire
May-22-20 07:30AM	Is Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Excessively Paying Its CEO? Simply Wall St.
May-20-20 06:15PM	Cumberland Pharmaceuticals (CPIX) Q1 Earnings and Revenues Miss Estimates Zacks
04:05PM	Cumberland Pharmaceuticals Reports First Quarter 2020 Financial Results & Company Update PR Newswire
02:30PM	Cumberland Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
May-15-20 04:40PM	Cumberland Pharmaceuticals To Announce First Quarter 2020 Financial Results PR Newswire
May-11-20 04:10PM	Vibativ® Sustained Potency Confirmed In Two Surveillance Studies PR Newswire
May-05-20 12:30PM	Analysts Estimate Cumberland Pharmaceuticals (CPIX) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-28-20 09:35AM	Cumberland Pharmaceuticals Releases Inaugural Report On Its Environmental, Social And Governance (ESG) Activities PR Newswire
Apr-17-20 08:37AM	Summit Therapeutics (SMMT) Catches Eye: Stock Jumps 8.9% Zacks
Apr-16-20 08:37AM	Ampio (AMPE) Looks Good: Stock Adds 5.2% in Session Zacks
Apr-07-20 05:00PM	To Help Prepare for the COVID-19 Patient Surge Cumberland Pharmaceuticals Expands Availability of Vaprisol® to Treat Hyponatremia in Critical Care Units PR Newswire
Apr-02-20 01:23PM	LLY, OXM, AMAG, MIST and CPIX as Zacks Bull and Bear of the Day Zacks
Mar-31-20 05:00PM	Cumberland Pharmaceuticals Announces Initiative to Expand Availability of Caldolor® to Help Treat High Fevers Associated With Coronavirus Infections PR Newswire
12:43PM	Penny Stocks to Buy Using Technical Analysis for April 2020 Investopedia
Mar-23-20 05:00PM	Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections PR Newswire
Mar-18-20 05:35PM	Cumberland Pharmaceuticals (CPIX) Q4 Earnings and Revenues Beat Estimates Zacks -7.11%
04:05PM	Cumberland Pharmaceuticals Reports 17% Revenue Growth For The Full Year 2019 PR Newswire
02:30PM	Cumberland Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Mar-17-20 09:35AM	Caldolor® Demonstrates Favorable Safety Profile In Newborns PR Newswire
Mar-11-20 12:30PM	Earnings Preview: Cumberland Pharmaceuticals (CPIX) Q4 Earnings Expected to Decline Zacks
Mar-06-20 04:35PM	Cumberland Pharmaceuticals Reschedules Fourth Quarter And Annual 2019 Financial Results PR Newswire
Mar-04-20 09:35AM	Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2019 Financial Results PR Newswire +15.86%
Jan-07-20 04:05PM	Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product PR Newswire
Jan-06-20 02:25PM	Edited Transcript of CPIX earnings conference call or presentation 12-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Jan-02-20 09:35AM	Cumberland Pharmaceuticals To Hold Update Call To Discuss Recent Major Developments PR Newswire
Dec-22-19 06:43PM	Cumberland Pharmaceuticals, Inc. (CPIX): Hedge Funds In Wait-and-See Mode Insider Monkey
Dec-04-19 09:21AM	New Strong Sell Stocks for December 4th Zacks
Dec-02-19 08:00AM	Cumberland Pharmaceuticals Receives FDA Approval for RediTrex Product Line PR Newswire +9.29%
Nov-25-19 09:35AM	New Study Reveals Real-World Usage of Vibativ® In a Variety Of Infections PR Newswire
Nov-12-19 04:05PM	Cumberland Pharmaceuticals Reports 22% Revenue Growth In The Third Quarter PR Newswire
Nov-05-19 05:45PM	Cumberland Pharmaceuticals (CPIX) Dips More Than Broader Markets: What You Should Know Zacks
11:24AM	What's in Store for Cumberland Pharma (CPIX) in Q3 Earnings? Zacks
10:32AM	Cumberland Pharmaceuticals (CPIX) to Report Q3 Results: Wall Street Expects Earnings Growth Zacks
09:35AM	Cumberland Pharmaceuticals To Announce Third Quarter 2019 Financial Results PR Newswire
Nov-02-19 10:30AM	Is Cumberland Pharmaceuticals (NASDAQ:CPIX) Using Too Much Debt? Simply Wall St.
Oct-30-19 05:45PM	Cumberland Pharmaceuticals (CPIX) Outpaces Stock Market Gains: What You Should Know Zacks
Oct-24-19 05:45PM	Cumberland Pharmaceuticals (CPIX) Stock Sinks As Market Gains: What You Should Know Zacks
Oct-16-19 05:50PM	Cumberland Pharmaceuticals (CPIX) Dips More Than Broader Markets: What You Should Know Zacks
Oct-15-19 09:35AM	New Study Reveals Superiority Of Vibativ® Over Vancomycin In Select Patients With Bacterial Pneumonia PR Newswire
Oct-10-19 05:45PM	Cumberland Pharmaceuticals (CPIX) Outpaces Stock Market Gains: What You Should Know Zacks
Oct-04-19 05:45PM	Cumberland Pharmaceuticals (CPIX) Stock Sinks As Market Gains: What You Should Know Zacks
Sep-26-19 11:01AM	New Strong Buy Stocks for September 26th Zacks +7.40%
Sep-25-19 12:25PM	Does Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) CEO Pay Matter? Simply Wall St.
Sep-24-19 09:35AM	Cumberland Pharmaceuticals Announces FDA Orphan Drug Grant Award For New Phase II Clinical Program PR Newswire
Sep-19-19 08:01AM	New Strong Buy Stocks for September 19th Zacks +5.38%
Sep-13-19 09:25AM	Cumberland Pharmaceuticals Sees Hammer Chart Pattern: Time to Buy? Zacks
Sep-12-19 10:26AM	New Strong Buy Stocks for September 12th Zacks
09:00AM	Cumberland (CPIX) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks
Sep-10-19 11:46AM	Theravance Announces Positive Early Data on JAK Inhibitor Zacks
Sep-09-19 09:50AM	New Strong Buy Stocks for September 9th Zacks +11.59%
Sep-06-19 10:33AM	Edited Transcript of CPIX earnings conference call or presentation 14-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
08:45AM	Here is Why Growth Investors Should Buy Cumberland (CPIX) Now Zacks
Sep-05-19 09:38AM	New Strong Buy Stocks for September 5th Zacks
Aug-21-19 08:45AM	Here is Why Growth Investors Should Buy Cumberland (CPIX) Now Zacks
Aug-14-19 05:25PM	Cumberland Pharmaceuticals (CPIX) Q2 Earnings Beat Estimates Zacks
04:05PM	Cumberland Pharmaceuticals Reports 14% Revenue Growth In The Second Quarter PR Newswire
07:24AM	Q2 Earnings Preview For Cumberland Benzinga
Aug-07-19 01:45PM	Cumberland Pharmaceuticals To Announce Second Quarter 2019 Financial Results PR Newswire
Aug-06-19 10:30AM	Cumberland Pharmaceuticals (CPIX) Earnings Expected to Grow: What to Know Ahead of Q2 Release Zacks
Jul-18-19 02:33PM	New antibiotics desperately needed for rising tide of drug-resistant superbugs American City Business Journals
Jul-12-19 02:30PM	When Will Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Turn A Profit? Simply Wall St.
Jul-05-19 10:09AM	Dova Pharmaceuticals (DOVA) in Focus: Stock Moves 9.1% Higher Zacks
Jun-26-19 08:32AM	Acer Shares Down on FDA's CRL for Genetic Disorder Treatment Zacks
Jun-25-19 05:50PM	Cumberland Pharmaceuticals (CPIX) Gains As Market Dips: What You Should Know Zacks
09:28AM	Why Taro Pharmaceutical (TARO) Could Be Positioned for a Slump Zacks
Jun-19-19 05:50PM	Cumberland Pharmaceuticals (CPIX) Stock Sinks As Market Gains: What You Should Know Zacks
08:25AM	The city's newest public company wants to build a new industry in Nashville American City Business Journals
Jun-18-19 10:25AM	Publicly traded San Diego firm moving HQ to Nashville American City Business Journals
Jun-04-19 10:08AM	The Zacks Analyst Blog Highlights: Flexible Solutions International, Qiwi, Cumberland Pharmaceuticals, CECO Environmental and Entravision Communications Zacks
09:30AM	Has Cumberland Pharmaceuticals (CPIX) Outpaced Other Medical Stocks This Year? Zacks
08:39AM	Nektar (NKTR) in Focus: Stock Moves 8.8% Higher Zacks

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and rheumatology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative, for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ injection, for the treatment of certain serious bacterial infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. The company markets and sells its products through sales representatives and district managers. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Galante Joseph C	Director	Aug 26	Buy	3.29	225	740	24,892	Aug 28 05:15 PM
Galante Joseph C	Director	Aug 21	Buy	3.35	375	1,256	24,667	Aug 28 05:15 PM
Galante Joseph C	Director	Aug 14	Buy	3.44	375	1,290	24,292	Aug 28 05:15 PM
Galante Joseph C	Director	Aug 07	Buy	3.42	375	1,282	23,917	Aug 28 05:15 PM
Galante Joseph C	Director	Jul 31	Buy	3.26	375	1,222	23,542	Aug 28 05:15 PM
Galante Joseph C	Director	Jul 24	Buy	3.33	375	1,249	23,167	Aug 28 05:15 PM
Galante Joseph C	Director	Jul 17	Buy	3.29	375	1,234	22,792	Aug 28 05:15 PM
Galante Joseph C	Director	Jul 10	Buy	3.31	375	1,241	22,417	Aug 28 05:15 PM
Galante Joseph C	Director	Jul 02	Buy	3.34	300	1,002	22,042	Aug 28 05:15 PM
Galante Joseph C	Director	Jun 26	Buy	3.37	375	1,264	21,742	Aug 28 05:15 PM
Galante Joseph C	Director	Jun 19	Buy	3.41	375	1,279	21,367	Aug 28 05:15 PM
Galante Joseph C	Director	Jun 12	Buy	3.37	225	758	20,992	Aug 28 05:15 PM
Galante Joseph C	Director	Jun 09	Buy	3.48	75	261	20,767	Jun 12 05:32 PM
Galante Joseph C	Director	Jun 08	Buy	3.54	75	266	20,692	Jun 12 05:32 PM
Galante Joseph C	Director	Jun 05	Buy	3.44	75	258	20,617	Jun 12 05:32 PM
Galante Joseph C	Director	Jun 04	Buy	3.31	75	248	20,542	Jun 12 05:32 PM
Galante Joseph C	Director	Jun 03	Buy	3.29	75	247	20,467	Jun 12 05:32 PM
Galante Joseph C	Director	Jun 02	Buy	3.35	75	251	20,392	Jun 12 05:32 PM
Galante Joseph C	Director	Jun 01	Buy	3.45	75	259	20,317	Jun 12 05:32 PM
Galante Joseph C	Director	May 29	Buy	3.35	75	251	20,242	Jun 12 05:32 PM
Galante Joseph C	Director	May 28	Buy	3.34	75	250	20,167	Jun 12 05:32 PM
Galante Joseph C	Director	May 27	Buy	3.49	75	262	20,092	Jun 12 05:32 PM
Galante Joseph C	Director	May 26	Buy	3.59	75	269	20,017	Jun 12 05:32 PM
Galante Joseph C	Director	May 22	Buy	3.61	75	271	19,942	Jun 12 05:32 PM
Galante Joseph C	Director	May 21	Buy	3.68	75	276	19,867	Jun 12 05:32 PM
Galante Joseph C	Director	May 20	Buy	3.77	75	283	19,792	Jun 12 05:32 PM
Galante Joseph C	Director	May 19	Buy	3.78	75	284	19,717	Jun 12 05:32 PM
Galante Joseph C	Director	May 18	Buy	3.82	75	286	19,642	Jun 12 05:32 PM
Galante Joseph C	Director	May 15	Buy	3.76	75	282	19,567	Jun 12 05:32 PM
Galante Joseph C	Director	May 14	Buy	3.81	75	286	19,492	Jun 12 05:32 PM
Galante Joseph C	Director	May 13	Buy	3.93	150	590	19,417	Jun 12 05:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience